Literature DB >> 34340979

Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al.

Maurizio Benucci1, Arianna Damiani2, Maria Infantino3, Mariangela Manfredi3, Valentina Grossi3, Barbara Lari3, Francesca Li Gobbi4, Piercarlo Sarzi Puttini5.   

Abstract

Entities:  

Keywords:  arthritis; rheumatoid; rituximab; vaccination

Year:  2021        PMID： 34340979     DOI： 10.1136/annrheumdis-2021-220829

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab.

Authors:  Victoria Furer; Tali Eviatar; Devy Zisman; Hagit Peleg; Yolanda Braun-Moscovici; Alexandra Balbir-Gurman; Daphna Paran; David Levartovsky; Michael Zisapel; Ofir Elalouf; Ilana Kaufman; Adi Broyde; Ari Polachek; Joy Feld; Amir Haddad; Tal Gazitt; Muna Elias; Nizar Higazi; Fadi Kharouf; Sara Pel; Sharon Nevo; Ori Elkayam
Journal:  Vaccines (Basel)       Date:  2022-06-06

2.  Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease.

Authors:  Giacomo Malipiero; Anna Moratto; Maria Infantino; Pierlanfranco D'Agaro; Elisa Piscianz; Mariangela Manfredi; Valentina Grossi; Enrico Benvenuti; Matteo Bulgaresi; Maurizio Benucci; Danilo Villalta
Journal:  Immunol Res       Date:  2021-08-21       Impact factor: 4.505

3.  COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis.

Authors:  Yusuke Ito; Akira Honda; Mineo Kurokawa
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2022-03-28

4.  Role of booster with BNT162b2 mRNA in SARS-CoV-2 vaccination in patients with rheumatoid arthritis.

Authors:  Maurizio Benucci; Arianna Damiani; Francesca Li Gobbi; Barbara Lari; Valentina Grossi; Maria Infantino; Mariangela Manfredi
Journal:  Immunol Res       Date:  2022-05-11       Impact factor: 4.505

5.  Humoral response to coronavirus disease-19 vaccines is dependent on dosage and timing of rituximab in patients with rheumatoid arthritis.

Authors:  Céleste J T van der Togt; David F Ten Cate; Nathan den Broeder; Janette Rahamat-Langendoen; Bart J F van den Bemt; Alfons A den Broeder
Journal:  Rheumatology (Oxford)       Date:  2022-06-28       Impact factor: 7.046
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.